---
title: "Genor Biopharma Announces Strategic Merger and Market Expansion Plans"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258911891.md"
description: "Genor Biopharma Holdings Limited (HK:6998) has announced a strategic merger and reverse takeover to expand its market presence. The company is collaborating with regulators and stakeholders to meet the necessary conditions for the merger, which is subject to approvals. These developments could significantly impact its operations and industry positioning. Genor Biopharma, incorporated in the Cayman Islands, focuses on innovative biologics and is listed on the Hong Kong Stock Exchange, with a current market cap of HK$2.04B and an average trading volume of 2,511,223."
datetime: "2025-09-25T14:10:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258911891.md)
  - [en](https://longbridge.com/en/news/258911891.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258911891.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/258911891.md) | [繁體中文](https://longbridge.com/zh-HK/news/258911891.md)


# Genor Biopharma Announces Strategic Merger and Market Expansion Plans

The latest update is out from Genor Biopharma Holdings Limited ( (HK:6998) ).

Genor Biopharma Holdings Limited has announced a series of strategic transactions, including a proposed merger and a reverse takeover, aimed at expanding its market presence. The company is working closely with regulators and stakeholders to address necessary conditions for the merger, which remains subject to approvals. These developments could significantly impact Genor Biopharma’s operations and industry positioning, though the outcome is contingent on regulatory and shareholder approvals.

**More about Genor Biopharma Holdings Limited**

Genor Biopharma Holdings Limited is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative biologics. The company is listed on the Hong Kong Stock Exchange and is involved in substantial acquisitions and mergers to enhance its market position.

**Average Trading Volume:** 2,511,223

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$2.04B

### Related Stocks

- [EDDING GENOR (06998.HK)](https://longbridge.com/en/quote/06998.HK.md)

## Related News & Research

- [Gold Pullback Brings Dip-Buying Window, Which Precious Metal Stocks Are Most Worth Watching?](https://longbridge.com/en/news/280897831.md)
- [Cn Logistics International Holdings FY revenue HKD 3,007.1 million](https://longbridge.com/en/news/281223361.md)
- [Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines](https://longbridge.com/en/news/280923090.md)
- [Assessing Securitas (OM:SECU B) Valuation After Recent Share Price Volatility](https://longbridge.com/en/news/280905109.md)
- [Skanska (OM:SKA B) Valuation Check After AGM Approval Of Ordinary And Extraordinary Dividend](https://longbridge.com/en/news/281342965.md)